Drug Profile
PF 4967544
Alternative Names: PF-04967544; PF4967544Latest Information Update: 01 Jun 2011
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Renal failure
Most Recent Events
- 27 Sep 2010 Phase-I development is ongoing
- 27 Jan 2010 Phase-I clinical trials in Renal failure in USA (unspecified route)